gotop

最新消息

  • link
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得澳洲發明專利
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得澳洲發明專利
    2021-01-08
  • link
    華上生醫新藥獲TFDA列諮詢輔導案將加速上市
    華上生醫新藥獲TFDA列諮詢輔導案將加速上市
    2020-12-24
  • link
    華上生醫自主開發「PH-SENSITIVE LINKERS FOR DELIVERING A THERAPEUTIC AGENT」取得韓國發明專利
    華上生醫自主開發「PH-SENSITIVE LINKERS FOR DELIVERING A THERAPEUTIC AGENT」取得韓國發明專利
    2020-12-17
  • link
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得紐西蘭發明專利
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得紐西蘭發明專利
    2020-11-13
  • link
    華上生醫申請「西達本胺/剋癌達TM」原料藥查驗登記暨DMF備查函
    華上生醫申請「西達本胺/剋癌達TM」原料藥查驗登記暨DMF備查函
    2020-11-12
  • link
    華上生醫獲得經濟部核准為生技新藥公司增列品項
    華上生醫研發製造產品之「GNTbm-CC-01」、「GNTbm-CC-02」等二項,獲得經濟部核准為生技新藥公司增列品項。
    2020-10-23